Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
PaperCitations, authors & open-access status
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,360 citations, 1999 year and closed oa status.
2,360
Citations
1999
Year
closed
OA Status